D145E
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
D145E is a point mutation on troponin C that leads to hypertrophic cardiomyopathy disease. This mutation is caused by the change of nucleotide C to A at nucleotide 435, switching the amino acid aspartic acid to glutamic acid, which is located at the C-terminal tail. Patients with this mutation have different structure on the thin filament and alter the binding of Ca 2+ at the troponin C site IV. Further, D145E causes increase in development of force and activation of ATPase in the presence of Ca 2+ .
D145E is a point mutation on troponin C that leads to hypertrophic cardiomyopathy disease. This mutation is caused by the change of nucleotide C to A at nucleotide 435, switching the amino acid aspartic acid to glutamic acid, which is located at the C-terminal tail. Patients with this mutation have different structure on the thin filament and alter the binding of Ca 2+ at the troponin C site IV. Further, D145E causes increase in development of force and activation of ATPase in the presence of Ca 2+ . ==References==
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374708929 under CC BY-SA 4.0; modifications have been made.